Healthcare - Biotechnology - NASDAQ - US
$ 17.85
-6.25 %
$ 668 M
Market Cap
12.4
P/E
INCOME STATEMENT
129 M
REVENUE
-3.16 M
OPERATING INCOME
-6.68 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Entrada Therapeutics, Inc.
| Revenue | 129 M |
| Cost Of Revenue | 99.9 M |
| Gross Profit | 29.1 M |
| Operating Expenses | 132 M |
| Operating Income | -3.16 M |
| Other Expenses | 3.52 M |
| Net Income | -6.68 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 129.0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 99.9 | 1.9 | 1.1 | 0.3 | 0.1 |
| Gross Profit | 29.1 | (1.9) | (1.1) | (0.3) | (0.1) |
| OPERATING INCOME | |||||
| Operating Expenses | 132.2 | 97.2 | 51.1 | 26.7 | 11.8 |
| Selling, General and Administrative Expenses | 32.3 | 30.6 | 15.2 | 5.6 | 3.6 |
| Research and Development Expenses | 99.9 | 66.6 | 35.9 | 21.1 | 8.2 |
| Operating Income | (3.2) | (97.2) | (51.1) | (26.7) | (11.8) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 2.6 | 31 K | 0 | 0 |
| Total Other Income | 15.2 | 2.6 | 31 K | 0.1 | 6.7 |
| Pre-Tax Income | 12.1 | (94.6) | (51.2) | (26.5) | (5.1) |
| NET INCOME | |||||
| Tax Provision | 18.7 | (7.2) | (1.1) | (0.1) | (0.5) |
| Net Income | (6.7) | (87.5) | (50.1) | (26.4) | (4.6) |
| EPS | 0.2 | 2.79 | 1.6 | 0.84 | 0.15 |